The market expects HealthEquity (HQY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on June 3, 2025, might help the stock move higher if these key numbers are bet ...

公司业绩表现 - 季度每股亏损0.07美元，远低于Zacks共识预期的0.65美元亏损，同比去年同期的0.39美元亏损有所改善 [1] - 季度营收396万美元，低于Zacks共识预期22.39%，同比去年同期的496万美元有所下降 [2] - 过去四个季度中，公司两次超过每股收益预期，但仅一次超过营收预期 [2] 市场反应与股价表现 - 季度业绩公布后股价立即变动取决于管理层在电话会议中的评论 [3] - 年初至今股价上涨17.3%，表现优于同期标普500指数1%的涨幅 [3] - 当前Zacks评级为3级(持有)，预计近期表现将与市场持平 [6] 未来展望 - 当前市场对下季度共识预期为每股亏损0.67美元，营收574万美元 [7] - 当前财年共识预期为每股亏损2.84美元，营收2436万美元 [7] - 未来业绩预期变化将影响股价走势，投资者可关注盈利预期修订趋势 [5] 行业情况 - 所属医疗-药品行业在Zacks行业排名中位列前21% [8] - 行业排名前50%的表现通常优于后50%，差距超过2:1 [8] 同业公司情况 - HealthEquity预计季度每股收益0.81美元，同比增长1.3% [9] - HealthEquity预计季度营收3.2113亿美元，同比增长11.7% [10] - 过去30天对其季度每股收益预期下调了0.2% [9]